Larimar Therapeutics (LRMR)

Larimar Therapeutics (LRMR) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• LRMR last traded at $2.37, -4.05% on the day.
• Larimar Therapeutics: market cap $256.59M, P/E -1.2, next earnings 2026-11-05.
• Over the past year LRMR returned -39.07%; year to date -37.80%.

Updated 2026-11-03 12:32 UTC